The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This poll finds the public's health care priorities for Congress focus on reducing out-of-pocket costs, and concerns over inflation and the economy are top of mind as voters begin to think about the November midterm elections. The poll also examines views of the ACA and nursing homes.
The Vaccine Monitor report examines how families and workers fared financially during the omicron surge. Large shares of workers missed work due to being sick from coronavirus, having to quarantine, or their workplace being closed due to the pandemic. Many, particularly those with lower incomes, report impacts on their family’s finances and stress level.
This Vaccine Monitor survey finds an increase in the share of parents reporting their child has received a COVID-19 vaccine, with 61% of parents of 12-17-year olds and 33% of 5-11-year-olds now saying their child has gotten at least one shot. Three in ten parents of children under the age of 5, a group that has not yet been approved to get a vaccine, say they’ll get their child vaccinated right away.
This annual survey of employers provides a detailed look at trends in employer-sponsored health coverage, including premiums, worker contributions, cost-sharing provisions, offer rates, and more. This year’s report also looks at how employers are addressing a growing need for mental health services.
This Vaccine Monitor survey finds about one in five parents of children under age five say they will get their child vaccinated right away, and another 38% plan to wait and see how the vaccine is working for others. With mask mandates lifted in many areas. most workers say they feel safe at their workplace, though Black, Hispanic and low-income workers are less likely to feel "very safe."
A new KFF COVID-19 Vaccine Monitor finds as many restrictions are being lifted, most of the public say they have personally returned to doing some of their pre-pandemic activities, but not all. In addition, majorities still report wearing masks in public indoor areas, but the public is split on whether the transportation mask mandate should continue. The pandemic has had a heavy toll on mental health, both for adults and their children, with people citing…
In the wake of the FDA's emergency use authorization for COVID-19 vaccines for children ages 6 months through 4 years old, many parents remain hesitant to vaccinate their children in this age group, with a slight majority saying they view the vaccine as a bigger risk to their child's health than getting infected with coronavirus.
Two years into the COVID-19 pandemic, the public is split on their readiness to return to normal, with many worried about the consequences of lifting restrictions and of not lifting them. At this point, the pandemic is not a top issue for voters in November's midterm elections . Most parents are not confident in the safety of the vaccine for kids under 5.
The latest Kaiser Health Tracking Poll continues to find pre-existing conditions as a widespread concern with most Americans saying it is very important that the Affordable Care Act’s (ACA) protections for people with pre-existing conditions remain law. With health care costs continuing to be a major topic in the 2018 campaigns, the poll looks at the public’s experiences with unexpected medical bills and finds that this tops a list of possible problems people could face.…
This data note from the latest KFF Health Tracking Poll explores the public's views on Medicare drug price negotiation, including how arguments on both sides impact support and opposition; confidence in leaders to do the right thing on drug pricing; and experiences with prescription drug costs.
© 2026 KFF